What does CORUM MARIAKERKE do?

CORUM MARIAKERKE is a logistics company in Gent. Private Limited, started on 30 November 1982, 2 establishments.

What is the address of CORUM MARIAKERKE?

The registered office of CORUM MARIAKERKE is located at Brugsesteenweg 343, 9030 Gent.

Is CORUM MARIAKERKE still active?

Yes. According to the CBE (31 October 2026) CORUM MARIAKERKE is active, legal situation “Normale toestand”, started on 30 November 1982.

Is CORUM MARIAKERKE registered on Peppol?

Yes, CORUM MARIAKERKE is registered on the Peppol network with ID 0208:0423277811.

What is the enterprise number of CORUM MARIAKERKE?

The enterprise number of CORUM MARIAKERKE is BE0423277811.

When was CORUM MARIAKERKE founded?

CORUM MARIAKERKE was founded on 30 November 1982.

Who are the directors of CORUM MARIAKERKE?

According to the 2026 annual accounts, the directors of CORUM MARIAKERKE are: CORUM PHARMA.

Is CORUM MARIAKERKE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 November 1982; 5 annual accounts filed, latest fiscal year 2026; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did CORUM MARIAKERKE make in 2026?

CORUM MARIAKERKE posted a profit after taxes of € 625 in financial year 2026.

What is the revenue of CORUM MARIAKERKE?

As a small company, CORUM MARIAKERKE is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € 251,689.

How much does an employee at CORUM MARIAKERKE earn?

The average wage cost per full-time employee at CORUM MARIAKERKE was € 77,100 in 2026: staff costs of € 200,403 for 2.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does CORUM MARIAKERKE have?

According to the 2026 annual accounts, CORUM MARIAKERKE has 2.6 full-time equivalents (FTE).

CORUM MARIAKERKE (Private Limited) - Gent - BE0423277811

Dossier CORUM MARIAKERKE, printed on 31 October 2026 from databakkes.be/en/0423277811/corum-mariakerke. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

CORUM MARIAKERKE from Gent, company number BE0423277811, closed financial year 2026 with a result of € 625 after tax. For that financial year CORUM MARIAKERKE recorded a gross margin of € 251,689 and equity of € 225,196. Compared with financial year 2025, the result moved from € 667 to € 625. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 26, 2026.

What it is worth Growing

€ 225,196

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 625

▼ 6% vs 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 138,783

▲ 46% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2026. Retained profit grew to € 206,598.

People and assets in 2026

Full-time equivalents

2.6

▲ 0.3 vs 2025

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 200,403

▲ 17% vs 2025

€ 77,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 1,049

▼ 44% vs 2025

Book value of vehicles, furniture and equipment.

Debts at end 2026

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 187,660

▼ 13% vs 2025

€ 29,948 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 95,170

▲ 72% vs 2025

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 33,385

▲ 4% vs 2025

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 134,278 Gross margin 2023: € 134,278 First fiscal year in the series	€ 184,670 Gross margin 2024: € 184,670 ▲ 38% vs 2023 (€ 134,278) Favourable step	€ 222,935 Gross margin 2025: € 222,935 ▲ 21% vs 2024 (€ 184,670) Favourable step	€ 251,689 Gross margin 2026: € 251,689 ▲ 13% vs 2025 (€ 222,935) Favourable step	▲ 13%
Profit after taxes	€ -16,059 Profit after taxes 2023: € -16,059 First fiscal year in the series	€ 11,932 Profit after taxes 2024: € 11,932 ▲ € 27,991 vs 2023 (€ -16,059) Favourable step	€ 667 Profit after taxes 2025: € 667 ▼ 94% vs 2024 (€ 11,932) Unfavourable step	€ 625 Profit after taxes 2026: € 625 ▼ 6% vs 2025 (€ 667) Unfavourable step	▼ 6%
Equity	€ 211,973 Equity 2023: € 211,973 First fiscal year in the series	€ 223,905 Equity 2024: € 223,905 ▲ 6% vs 2023 (€ 211,973) Favourable step	€ 224,572 Equity 2025: € 224,572 Unchanged (€ 223,905) Favourable step	€ 225,196 Equity 2026: € 225,196 Unchanged (€ 224,572) Favourable step
Total debts	€ 549,159 Total debts 2023: € 549,159 First fiscal year in the series	€ 465,357 Total debts 2024: € 465,357 ▼ 15% vs 2023 (€ 549,159) Favourable step	€ 422,108 Total debts 2025: € 422,108 ▼ 9% vs 2024 (€ 465,357) Favourable step	€ 440,848 Total debts 2026: € 440,848 ▲ 4% vs 2025 (€ 422,108) Unfavourable step	▲ 4%
Cash	€ 85,752 Cash 2023: € 85,752 First fiscal year in the series	€ 135,099 Cash 2024: € 135,099 ▲ 58% vs 2023 (€ 85,752) Favourable step	€ 94,780 Cash 2025: € 94,780 ▼ 30% vs 2024 (€ 135,099) Unfavourable step	€ 138,783 Cash 2026: € 138,783 ▲ 46% vs 2025 (€ 94,780) Favourable step	▲ 46%
Retained profit	€ 193,375 Retained profit 2023: € 193,375 First fiscal year in the series	€ 205,307 Retained profit 2024: € 205,307 ▲ 6% vs 2023 (€ 193,375) Favourable step	€ 205,974 Retained profit 2025: € 205,974 Unchanged (€ 205,307) Favourable step	€ 206,598 Retained profit 2026: € 206,598 Unchanged (€ 205,974) Favourable step
Bank debt	€ 271,421 Bank debt 2023: € 271,421 First fiscal year in the series	€ 244,331 Bank debt 2024: € 244,331 ▼ 10% vs 2023 (€ 271,421) Favourable step	€ 216,519 Bank debt 2025: € 216,519 ▼ 11% vs 2024 (€ 244,331) Favourable step	€ 187,660 Bank debt 2026: € 187,660 ▼ 13% vs 2025 (€ 216,519) Favourable step	▼ 13%
Balance sheet total	€ 761,132 Balance sheet total 2023: € 761,132 First fiscal year in the series	€ 689,262 Balance sheet total 2024: € 689,262 ▼ 9% vs 2023 (€ 761,132) Unchanged	€ 646,679 Balance sheet total 2025: € 646,679 ▼ 6% vs 2024 (€ 689,262) Unchanged	€ 666,044 Balance sheet total 2026: € 666,044 ▲ 3% vs 2025 (€ 646,679) Unchanged	▲ 3%
Employees (FTE)	2 Employees (FTE) 2023: 2 First fiscal year in the series	2.1 Employees (FTE) 2024: 2.1 ▲ 0.1 vs 2023 (2) Unchanged	2.3 Employees (FTE) 2025: 2.3 ▲ 0.2 vs 2024 (2.1) Unchanged	2.6 Employees (FTE) 2026: 2.6 ▲ 0.3 vs 2025 (2.3) Unchanged	▲ 0.3

Key figures of CORUM MARIAKERKE, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 October 2027.

What happened to CORUM MARIAKERKE?

What happened at CORUM MARIAKERKE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 26, 2026 New annual accounts for financial year 2026: profit of € 625 (▼ 6% vs 2025). Source: NBB ↗
2021 CORUM PHARMA became a director. NBB
Jun 18, 1996 New establishment in Koksijde. KBO
Nov 30, 1982 Start of the company according to the CBE. KBO
Nov 1, 1982 New establishment in Gent. KBO

In short

From € 16,059 loss in 2023 to € 625 profit in 2026.

Best year ever: 2024, with € 11,932 profit.

On average € 96,800 of value added per employee in 2026.

Original PDFs at the National Bank ↗

Management

CORUM PHARMA 100%

The stake of CORUM PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

CORUM MARIAKERKE

Behind CORUM MARIAKERKE is CORUM PHARMA. The shares are held by CORUM PHARMA (100%).

Directors

According to the 2026 annual accounts

CORUM PHARMA

Director · represented by Laurence Vanneste

since 2021

Shareholders

CORUM PHARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Brugsesteenweg 343

9030 Gent

2.021.443.772

Brugsesteenweg 374

9030 Gent

Active since 1 November 1982

2.021.443.871

E. Vanlangenhovestraat(Kok) 4 box 104

8670 Koksijde

Active since 18 June 1996

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0423.277.811

VAT number

BE 0423.277.811

Registered office

Brugsesteenweg 343, 9030 Gent

Names & denominations

CORUM MARIAKERKE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 November 1982

Peppol

Active · Active since 20 Aug 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

CORUM MARIAKERKE

Financials

What happened to CORUM MARIAKERKE?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions